Abstract
Abnormal bleeding can occur after any invasive procedure, and it is seen more frequently after emergency surgery than after elective procedures. Ideally, bleeding complications are prevented by a careful medical history before surgery and laboratory investigation when a hemostatic defect can be suspected. When pre- or postoperative bleeding complication occurs, all available information from medical history, drug intake, inspection of the wound, other signs on physical examination, and screening laboratory tests should be taken into account to understand the cause of bleeding and to give adequate hemostatic therapy. There are approximate guidelines when red cells, platelets, plasma, cryoprecipitate, or fibrinogen should be given. The level of evidence is generally low but most of the measures can be physiologically justified.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- aPTT:
-
Activated partial thromboplastin time
- ASA:
-
Acetylsalicylic acid
- CBC:
-
Complete blood count
- CI:
-
Confidence interval
- DIC:
-
Disseminated intravascular coagulation
- NSAIDs:
-
Nonsteroid anti-inflammatory agents
- PBAC:
-
Pictorial bleeding assessment chart
- PCC:
-
Prothrombin complex concentrate
- PT:
-
Prothrombin time
- rFVIIa:
-
Recombinant activated factor VIIa
- TCT:
-
Thrombin clotting time
- VWD:
-
von Willebrand disease
References
Ak K, Isbir CS, Tetik S, Atalan N, Tekeli A, Aljodi M et al (2009) Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg 24:404–410
Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM (2011) Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 93:1577–1585
Avidan MS, Alcock EL, Da Fonseca J, Ponte J, Desai JB, Despotis GJ et al (2004) Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 92:178–186
Bolton-Maggs PH, Colvin BT, Satchi BT, Lee CA, Lucas GS (1994) Thrombogenic potential of factor XI concentrate. Lancet 344:748–749
Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK et al (2012) Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 157:49–58
Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F et al (2010) Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. Artif Organs 34:955–960
Dager W, Roberts A (2011) Reversing dabigatran with FEIBA in a patient with a transseptal perforation during cardiac ablation. Crit Care Med 39(Suppl):243
Dentali F, Marchesi C, Pierfranceschi MG, Crowther M, Garcia D, Hylek E et al (2011) Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost 106:429–438
Eckman MH, Erban JK, Singh SK, Kao GS (2003) Screening for the risk for bleeding or thrombosis. Ann Intern Med 138:W15–W24
Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M (2011) Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 124:1573–1579
Gill JB, Rosenstein A (2006) The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis. J Arthroplasty 21:869–873
Gill JB, Chin Y, Levin A, Feng D (2008) The use of antifibrinolytic agents in spine surgery. A meta-analysis. J Bone Joint Surg Am 90:2399–2407
Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S et al (2012) Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the randomized evaluation of long-term anticoagulation therapy (RE-LY) randomized trial. Circulation 126:343–348
Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417
Henry D, Carless P, Fergusson D, Laupacis A (2009) The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ 180: 183–193
Houry S, Georgeac C, Hay JM, Fingerhut A, Boudet MJ (1995) A prospective multicenter evaluation of preoperative hemostatic screening tests. The French Associations for Surgical Research. Am J Surg 170:19–23
Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Flinck A, Skrtic S et al (2009) Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 102:137–144
Levi M, Levy JH, Andersen HF, Truloff D (2010) Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 363:1791–1800
Lewis B, O’Leary M, Vinh T (2001) Successful use of rVIIa (NovoSeven) to reverse enoxaparin (Lovenox) overdose in an adult patient with intracranial bleeding. Thromb Haemost 86(Suppl 1):P2633
Lisman T, Bijsterveld NR, Adelmeijer J, Meijers JC, Levi M, Nieuwenhuis HK et al (2003) Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux. J Thromb Haemost 1:2368–2373
Marlu R, Hodaj E, Paris A, Albaladejo P, Crackowski JL, Pernod G (2012) Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban. A randomised crossover ex vivo study in healthy volunteers. Thromb Haemost 108:217–224
Pappas AM, Barr JS, Salzman EW, Britten A, Riseborough EJ (1964) The problem of unrecognized “mild hemophilia.” Survival of a patient after disarticulation of the hip. JAMA 187:772–774
Peyvandi F, Jayandharan G, Chandy M, Srivastava A, Nakaya SM, Johnson MJ et al (2006) Genetic diagnosis of haemophilia and other inherited bleeding disorders. Haemophilia 12(Suppl 3):82–89
Philipp CS, Faiz A, Heit JA, Kouides PA, Lukes A, Stein SF et al (2011) Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia. Am J Obstet Gynecol 204:209.e1–209.e7
American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies (2006) Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 105: 198–208
Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P et al (2010) ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 8:2063–2065
Schulman S (2003) Care of patients receiving long-term anticoagulant therapy. N Engl J Med 349:675–683
Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692–694
Schulman S, Nemeth G (2006) An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency. Haemophilia 12: 223–227
Schulman S, Bijsterveld NR (2007) Anticoagulants and their reversal. Transfus Med Rev 21:37–48
Schulman S, Angeras U, Bergqvist D, Eriksson B, Lassen MR, Fisher W (2010) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 8: 202–204
Shargorodsky J, Hartnick CJ, Lee GS (2012) Dexamethasone and postoperative bleeding after tonsillectomy and adenotonsillectomy in children: A meta-analysis of prospective studies. Laryngoscope 122:1158–1164
Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA (1999) Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 88:312–319
Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC (2012) Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 126:1630–1639
Stangier J, Rathgen K, Stahle H, Mazur D (2010) Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study. Clin Pharmacokinet 49:259–268
Tomkinson A, Harrison W, Owens D, Fishpool S, Temple M (2012) Postoperative hemorrhage following adenoidectomy. Laryngoscope 122:1246–1253
Warkentin TE, Margetts P, Connolly S, Lamy A, Ricci C (2012) Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. Blood 119:2172–2174
Wei JL, Beatty CW, Gustafson RO (2000) Evaluation of posttonsillectomy hemorrhage and risk factors. Otolaryngol Head Neck Surg 123:229–235
Westbrook AJ, Olsen J, Bailey M, Bates J, Scully M, Salamonsen RF (2009) Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study. Heart Lung Circ 18:277–288
Zufferey PJ, Miquet M, Quenet S, Martin P, Adam P, Albaladejo P et al (2010) Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth 104:23–30
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schulman, S. (2014). Prolonged Bleeding After Surgery. In: Lichtin, A., Bartholomew, J. (eds) The Coagulation Consult. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9560-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9560-4_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9559-8
Online ISBN: 978-1-4614-9560-4
eBook Packages: MedicineMedicine (R0)